ebos group limited (ebo:ax, ebo.nz) - asxebos 1h fy18 summary results 7 delivering results 1,822...
Post on 02-Feb-2021
2 Views
Preview:
TRANSCRIPT
-
EBOS Group Limited (EBO:AX, EBO.NZ)John Cullity CEO ElectASX CEO Connect Series – March 2018
-
2
ANIMAL CAREHEALTHCARE
EBOS Group Today
COMMUNITY PHARMACY
CONSUMER PRODUCTS
INSTITUTIONAL HEALTHCARE
CONTRACT LOGISTICS RETAIL
PRODUCT & BRANDS
VET WHOLESALE
NZ$2.7BMarket Capitalisation
NZX/ASX Dual listed
$7.6 billionFY17 Revenue
21%Annualised shareholder return last 4 Years
No.1Combined pharmacy and hospital pharmaceutical wholesaler in Australia & NZ
Investments
-
3
EBOS Group strategic approach
Investing for Growth Leading Market PositionsDisciplined Capital
Management
• Cash generation to drive scope for further investment which allows for dividends paid in the range of 60-70% of Net Profit After Tax
• Acquisitions focus on improving Group returns on capital employed
Our Healthcare and Animal Care strategic focus is centred on:
We aim to have positions of scale in the markets we operate in and maximise opportunities across our wide range of business segments wherever possible
Two types of investments:
• External acquisitions – we have a strong history of deal execution
• Internal Capex – investment to lift productivity, manage cost and deliver better customer service
We focus on delivering profitable growth and superior returns
-
4
Recent Investment HighlightsRecent Acquisitions & Investments Major Capacity Expansion
TWC Investment: October 2016• Merger of Chemmart and Terry
White has created of one of the largest retail pharmacy store networks in Australia.
HPS Acquired: June 2017• Australia’s largest provider of
outsourced pharmacy services to Hospitals.
Significant progress made on three key capex projects in Australia & NZ• New Wholesale Distribution site
Brisbane, Queensland
• New Contract Logistics siteSydney, New South Wales
• New Wholesale Distribution siteChristchurch, NZ
BlackHawk expansion: July 2017• BH launched into the New Zealand
market• BH is now Australia’s and NZ’s fastest
growing premium pet food.
MedAdvisor investment: October 2017 • Cornerstone investment made in
Australia’s leading digital medication management company Construction progress: New Brisbane site (Queensland)
-
5
• Australia’s fastest growing premium pet food brand with a leading position in the pet specialty retail channel.
• Sales growth in 1H 2018 of +26%
• In July 2017 Black Hawk was launched in the New Zealand market. Initial results are very positive.
Black Hawk Update
FY14 FY15 FY16 FY17
Black Hawk Sales (pre and post acquisition)
+48%
+55%
+23%
-
6
Constant FXNZ$m H1 FY18 H1 FY17 Var VarRevenue 3,942.7 3,960.2 (0.4%) (3.8%)
Gross Operating Revenue 434.8 364.1 19.4% 15.5%
EBITDA 138.5 119.9 15.6% 11.7%
EBIT 121.2 107.5 12.7% 9.0%
Net Profit After Tax 76.7 68.8 11.5% 7.8%
Underlying EBITDA 138.5 122.3 13.3% 9.5%
Underlying NPAT 76.7 70.2 9.1% 5.5%
Adjusted EPS - cps 51.4 46.4 10.8% 7.1%
Net Debt 447.5 288.1
Net Debt : EBITDA 1.76x 1.25x
ROCE 16.1% 16.2%
EBOS 1H FY18 Summary results
-
7
Delivering Results
1,822
5,757
6,395
7,101
7,626
FY13
FY14
FY15
FY16
FY17
57.0
175.4
215.7
225.5
241.4
FY13
FY14
FY15
FY16
FY17
41.0 47.0 58.5 63.0
FY14 FY15 FY16 FY17
5 Year Revenue TrendNZ$m
Dividends per sharecents
5 Year EBITDA TrendNZ$m
6
8
10
12
14
16
18
20
30/06/2012 30/06/2013 30/06/2014 30/06/2015 30/06/2016 30/06/2017
Share PriceFY13 to FY17
-
8
Summary - what to expect
• Continue to execute on our strategy of organic growth and bolt on acquisitions
• Maintain our disciplined approach to cash flow and capital management
• Maintain a strong balance sheet with capacity for acquisition opportunities
• Focus on our customers, partners and shareholder returns
-
www.ebosgroup.com
EBOS Group Limited (EBO:AX, EBO.NZ)� John Cullity CEO Elect� ASX CEO Connect Series – March 2018EBOS Group TodayEBOS Group strategic approachRecent Investment HighlightsBlack Hawk UpdateEBOS 1H FY18 Summary resultsDelivering ResultsSlide Number 8Slide Number 9
top related